{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:33:48Z","timestamp":1772620428358,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.therap.2024.10.062","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T22:31:42Z","timestamp":1733437902000},"page":"47-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Methodological expectations for demonstration of health product effectiveness by observational studies"],"prefix":"10.1016","volume":"80","author":[{"given":"Michel","family":"Cucherat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Demarcq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Chassany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Le Jeunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Borget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Collignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Diebolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Feuilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Fiquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e9mence","family":"Leyrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Naudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rapha\u00ebl","family":"Porcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Schmidely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabassome","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Roustit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2024.10.062_bib0350","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jacc.2020.05.069","article-title":"Randomized trials versus common sense and clinical observation: JACC review topic of the week","volume":"76","author":"Fanaroff","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0355","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamacardio.2016.1792","article-title":"Randomization\u00a0-\u00a0there is no substitute","volume":"1","author":"Fonarow","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0360","doi-asserted-by":"crossref","first-page":"i493","DOI":"10.1136\/bmj.i493","article-title":"Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey","volume":"352","author":"Hemkens","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2024.10.062_bib0365","doi-asserted-by":"crossref","first-page":"e073100","DOI":"10.1136\/bmj-2022-073100","article-title":"Replacing RCTs with real world data for regulatory decision making: a self-fulfilling prophecy?","volume":"380","author":"Wieseler","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2024.10.062_bib0370","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMp2200089","article-title":"Real-world evidence\u00a0\u2014\u00a0where are we now?","volume":"386","author":"Concato","year":"2022","journal-title":"New Engl J Med"},{"key":"10.1016\/j.therap.2024.10.062_bib0375","series-title":"Real world evidence framework to support EU regulatory decision making","year":"2023"},{"key":"10.1016\/j.therap.2024.10.062_bib0380","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.clinthera.2022.01.012","article-title":"Real-world evidence for regulatory decision-making: guidance from around the world","volume":"44","author":"Burns","year":"2022","journal-title":"Clinical Ther"},{"key":"10.1016\/j.therap.2024.10.062_bib0385","series-title":"Real-world evidence: considerations regarding non-interventional studies for drug and biological products guidance for industry","year":"2024"},{"key":"10.1016\/j.therap.2024.10.062_bib0390","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.2024.7741","article-title":"Causal inference about the effects of interventions from observational studies in medical journals","volume":"331","author":"Dahabreh","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2024.10.062_bib0395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.therap.2019.12.002","article-title":"Des \u00e9tudes mono-bras aux \u00e9tudes de comparaison externe. Consid\u00e9rations m\u00e9thodologiques et recommandations","volume":"75","author":"Cucherat","year":"2020","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2024.10.062_bib0400","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cpt.329","article-title":"Transparency and reproducibility of observational cohort studies using large healthcare databases","volume":"99","author":"Wang","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.therap.2024.10.062_bib0405","doi-asserted-by":"crossref","first-page":"e076460","DOI":"10.1136\/bmj-2023-076460","article-title":"A PRocess guide for INferential studies using healthcare data from routine ClinIcal Practice to EvaLuate causal Effects of Drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation Center","volume":"384","author":"Desai","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2024.10.062_bib0410","series-title":"Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence - Scientific guideline","year":"2024"},{"key":"10.1016\/j.therap.2024.10.062_bib0415","unstructured":"CIOMS. Real-world data and real-world evidence in regulatory decision making: CIOMS 2024. https:\/\/cioms.ch\/publications\/product\/real-world-data-and-real-world-evidence-in-regulatory-decision-making\/#:\u223c:text=This%20report%20was%20developed%20to%20inform%20discussions%20about%20the%20use. [Accessed 7 October 2024]."},{"key":"10.1016\/j.therap.2024.10.062_bib0420","series-title":"\u00c9tudes en vie r\u00e9elle pour l\u2019\u00e9valuation des m\u00e9dicaments et dispositifs m\u00e9dicaux","year":"2021"},{"key":"10.1016\/j.therap.2024.10.062_bib0425","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jclinepi.2017.09.013","article-title":"Interpretation of epidemiologic studies very often lacked adequate consideration of confounding","volume":"93","author":"Hemkens","year":"2018","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0430","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jclinepi.2021.11.013","article-title":"Let's end \u201creal-world evidence\u201d terminology usage: a study should be identified by its design","volume":"142","author":"Pacheco","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0435","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/cpt.2255","article-title":"When can nonrandomized studies support valid inference regarding effectiveness or safety of new medical treatments?","volume":"111","author":"Franklin","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.therap.2024.10.062_bib0440","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1001\/jamaoncol.2021.3537","article-title":"Inferential challenges for real-world evidence in the era of routinely collected health data: many researchers, many more hypotheses, a single database","volume":"7","author":"Panagiotou","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.therap.2024.10.062_bib0445","doi-asserted-by":"crossref","first-page":"230568","DOI":"10.1098\/rsos.230568","article-title":"Reducing bias in secondary data analysis via an Explore and Confirm Analysis Workflow (ECAW): a proposal and survey of observational researchers","volume":"10","author":"Thibault","year":"2023","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.therap.2024.10.062_bib0450","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1207\/s15327957pspr0203_4","article-title":"HARKing: hypothesizing after the results are known","volume":"2","author":"Kerr","year":"1998","journal-title":"Pers Soc Psychol Rev"},{"key":"10.1016\/j.therap.2024.10.062_bib0455","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/pds.4297","article-title":"Good practices for real-world data studies of treatment and\/or comparative effectiveness: recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making","volume":"26","author":"Berger","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.therap.2024.10.062_bib0460","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10654-021-00778-w","article-title":"Modern Epidemiology, 4th ed. TL Lash, TJ VanderWeele, S Haneuse, KJ Rothman. Wolters Kluwer, 2021","volume":"36","author":"Ahlbom","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0465","doi-asserted-by":"crossref","first-page":"e076460","DOI":"10.1136\/bmj-2023-076460","article-title":"Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation Center","volume":"384","author":"Desai","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2024.10.062_bib0470","doi-asserted-by":"crossref","first-page":"e076123","DOI":"10.1136\/bmj-2023-076123","article-title":"Improving the transparency and reliability of observational studies through registration","volume":"384","author":"Naudet","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2024.10.062_bib0475","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12874-020-00942-y","volume":"20","author":"Huebner","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.therap.2024.10.062_bib0480","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007513","article-title":"Making prospective registration of observational research a reality","volume":"6","author":"Dal-R\u00e9","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.therap.2024.10.062_bib0485","series-title":"OCE. Real-world data: assessing electronic health records and medical claims data to support regulatory decision-making for drug and biological products","year":"2024"},{"key":"10.1016\/j.therap.2024.10.062_bib0490","series-title":"Causal inference. What if","author":"Hern\u00e1n","year":"2020"},{"key":"10.1016\/j.therap.2024.10.062_bib0495","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jech.2002.006361","article-title":"A definition of causal effect for epidemiological research","volume":"58","author":"Hern\u00e1n","year":"2004","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.therap.2024.10.062_bib0500","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMp2113319","article-title":"Methods of public health research - strengthening causal inference from observational data","volume":"385","author":"Hern\u00e1n","year":"2021","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1016\/j.therap.2024.10.062_bib0505","article-title":"The causal cookbook: recipes for propensity scores, g-computation, and doubly robust standardization","volume":"7","author":"Chatton","year":"2024","journal-title":"Adv Methods Pract Psychol Sci"},{"key":"10.1016\/j.therap.2024.10.062_bib0510","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/ije\/dyab050","article-title":"Analyses of \u2018change scores\u2019 do not estimate causal effects in observational data","volume":"51","author":"Tennant","year":"2022","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0515","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/aje\/kwad012","article-title":"Defining and identifying average treatment effects","volume":"192","author":"Naimi","year":"2023","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0520","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1002\/sim.8741","article-title":"Formulating causal questions and principled statistical answers","volume":"39","author":"Goetghebeur","year":"2020","journal-title":"Stat Med"},{"key":"10.1016\/j.therap.2024.10.062_bib0525","article-title":"Choosing the causal estimand for propensity score analysis of observational studies","author":"Greifer","year":"2021","journal-title":"arXiv"},{"key":"10.1016\/j.therap.2024.10.062_bib0530","series-title":"ICH E9 (R1) addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials.","year":"2020"},{"key":"10.1016\/j.therap.2024.10.062_bib0535","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1017\/cts.2023.635","article-title":"A causal roadmap for generating high-quality real-world evidence","volume":"7","author":"Dang","year":"2023","journal-title":"J Clin Trans Sci"},{"key":"10.1016\/j.therap.2024.10.062_bib0540","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jama.2022.1816","article-title":"Causal directed acyclic graphs","volume":"327","author":"Lipsky","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2024.10.062_bib0545","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/resp.12238","article-title":"Introduction to causal diagrams for confounder selection","volume":"19","author":"Williamson","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.therap.2024.10.062_bib0550","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jclinepi.2021.08.001","article-title":"Tutorial on directed acyclic graphs","volume":"142","author":"Digitale","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0555","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jclinepi.2022.05.021","article-title":"Avoiding overadjustment bias in social epidemiology through appropriate covariate selection: a primer","volume":"149","author":"van Zwieten","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0560","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1038\/s41467-020-19478-2","article-title":"Collider bias undermines our understanding of COVID-19\u00a0disease risk and severity","volume":"11","author":"Griffith","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.therap.2024.10.062_bib0565","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/EDE.0000000000001724","article-title":"Using negative control populations to assess unmeasured confounding and direct effects","volume":"35","author":"Piccininni","year":"2024","journal-title":"Epidemiology"},{"key":"10.1016\/j.therap.2024.10.062_bib0570","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jama.2013.3089","article-title":"Falsification end points for observational studies","volume":"309","author":"Groenwold","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2024.10.062_bib0575","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/j.therap.2024.10.062_bib0580","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jama.2012.96867","article-title":"Prespecified falsification end points: can they validate true observational associations?","volume":"309","author":"Prasad","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2024.10.062_bib0585","doi-asserted-by":"crossref","first-page":"e076365","DOI":"10.1136\/bmj-2023-076365","article-title":"Quantifying possible bias in clinical and epidemiological studies with quantitative bias analysis: common approaches and limitations","volume":"385","author":"Brown","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2024.10.062_bib0590","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2018.21554","article-title":"Using the e-value to assess the potential effect of unmeasured confounding in observational studies","volume":"321","author":"Haneuse","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2024.10.062_bib0595","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the e-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.therap.2024.10.062_bib0600","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2024.10.062_bib0605","series-title":"Applying quantitative bias analysis to epidemiologic data","author":"Fox","year":"2021"},{"key":"10.1016\/j.therap.2024.10.062_bib0610","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/EDE.0000000000001714","article-title":"A quantitative bias analysis approach to informative presence bias in electronic health records","volume":"35","author":"Zhang","year":"2024","journal-title":"Epidemiology"},{"key":"10.1016\/j.therap.2024.10.062_bib0615","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/EDE.0000000000001231","article-title":"Benchmarking observational methods by comparing randomized trials and their emulations","volume":"31","author":"Dahabreh","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.therap.2024.10.062_bib0620","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10654-024-01119-3","article-title":"Prospective benchmarking of an observational analysis in the SWEDEHEART registry against the REDUCE-AMI randomized trial","volume":"39","author":"Matthews","year":"2024","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta25510","article-title":"Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results","volume":"25","author":"Wing","year":"2021","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.therap.2024.10.062_bib0630","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: a framework for causal inference from observational data","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2024.10.062_bib0635","doi-asserted-by":"crossref","first-page":"e071108","DOI":"10.1136\/bmj-2022-071108","article-title":"Target trial emulation: applying principles of randomised trials to observational studies","volume":"378","author":"Matthews","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2024.10.062_bib0640","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses","volume":"79","author":"Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0645","article-title":"Efficacy versus effectiveness: The HORIZON pivotal fracture trial and its emulation in claims data","author":"D\u2019Andrea","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.therap.2024.10.062_bib0650","series-title":"Guidance document. Demonstrating substantial evidence of effectiveness for human drug and biological products. Draft guidance for industry.","year":"2019"},{"key":"10.1016\/j.therap.2024.10.062_bib0655","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/jama.2023.4221","article-title":"Emulation of randomized clinical trials with nonrandomized database analyses: results of 32\u00a0clinical trials","volume":"329","author":"Wang","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2024.10.062_bib0660","doi-asserted-by":"crossref","first-page":"e000709","DOI":"10.1136\/bmjmed-2023-000709","article-title":"Design differences and variation in results between randomised trials and non-randomised emulations: meta-analysis of RCT-duplicate data","volume":"3","author":"Heyard","year":"2024","journal-title":"BMJMed"},{"key":"10.1016\/j.therap.2024.10.062_bib0665","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/annrheumdis-2020-217200","article-title":"Improving rheumatoid arthritis comparative effectiveness research through causal inference principles: systematic review using a target trial emulation framework","volume":"79","author":"Zhao","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.therap.2024.10.062_bib0670","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jclinepi.2023.08.003","article-title":"The implementation of target trial emulation for causal inference: a scoping review","volume":"162","author":"Zuo","year":"2023","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.therap.2024.10.062_bib0675","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12874-019-0879-5","article-title":"DEBATE-statistical analysis plans for observational studies","volume":"19","author":"Hiemstra","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.therap.2024.10.062_bib0680","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2024.10.062_bib0685","doi-asserted-by":"crossref","first-page":"m4856","DOI":"10.1136\/bmj.m4856","article-title":"STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies","volume":"372","author":"Wang","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.therap.2024.10.062_bib0690","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/pds.5079","article-title":"Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how: recommendations and a road map from the real-world evidence transparency initiative","volume":"29","author":"Orsini","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595724002063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595724002063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T13:57:59Z","timestamp":1739023079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595724002063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0040595724002063"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2024.10.062","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methodological expectations for demonstration of health product effectiveness by observational studies","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2024.10.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2024.10.052","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}